Abstract
We investigated whether baseline brain arousal instability during resting state EEG, using the Vigilance Algorithm Leipzig (VIGALL 2.1), can predict response to methylphenidate therapy in adult ADHD patients. An arousal stability score of the EEGs of 28 adult ADHD patients was calculated quantifying the extent of arousal decline. In logistic regression analysis, arousal stability score predicted response to MPH [odds ratio 1.28 (95% CI 1.0–1.65); p = 0.027]. In this pilot study, we demonstrated that arousal stability at baseline predicted methylphenidate treatment response, indicating that less stable arousal regulation during a 15-min EEG at rest increases the chance of treatment response.
References
Fayyad J et al (2017) The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord 9(1):47–65
Biederman J et al (2012) Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 73(7):941–950
Nierenberg AA et al (2005) Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry 57(11):1467–1473
Hegerl U, Hensch T (2014) The vigilance regulation model of affective disorders and ADHD. Neurosci Biobehav Rev 44:45–57
Hegerl U et al (2010) Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry 23(1):1–7
Guenther T et al (2011) Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment. Neuroimage 56(1):93–101
Huang J et al (2017) Evoked potentials and behavioral performance during different states of brain arousal. BMC Neurosci 18(1):21
Jawinski P (2017) Recorded and reported sleepiness the association between brain arousal in resting state and subjective daytime sleepiness. Sleep 40(7)
Olbrich S et al (2012) EEG vigilance regulation patterns and their discriminative power to separate patients with major depression from healthy controls. Neuropsychobiology 65(4):188–194
Huang J et al (2018) Impact of brain arousal and time-on-task on autonomic nervous system activity in the wake-sleep transition. BMC Neurosci
Ulke C et al (2017) Coupling and dynamics of cortical and autonomic signals are linked to central inhibition during the wake-sleep transition. Sci Rep 7:11804
Sander C et al (2010) EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder. Clin Neurophysiol 121(9):1511–1518
Strauss M et al (2018) Brain arousal regulation in adults with attention-deficit/hyperactivity disorder (ADHD). Psychiatry Res 261:102–108
Retz-Junginger P et al (2002) Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 73(9):830–838
Rosler M et al (2006) Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 256(Suppl 1):i3-11
Ulke C et al (2017) Sleep disturbances and upregulation of brain arousal during daytime in depressed versus non-depressed elderly subjects. World J Biol Psychiatry 18(8):633–640
Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32–35
Clarke AR et al (2013) Excess beta activity in the EEG of children with attention-deficit/hyperactivity disorder: a disorder of arousal? Int J Psychophysiol 89(3):314–319
Clarke AR et al (2002) Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology 164(3):277–284
Acknowledgements
We thank Petra Pfaff-Ott for technical assistance and all patients for participating in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
MS is a speaker for Lilly, Medice Arzneimittel and Servier. MP reports grants from Novartis Pharma GmbH, Germany and personal fees from Medice outside the submitted work. UH was an advisory board member for Lilly, Lundbeck, Servier, Takeda and Otsuka; a consultant for Bayer and Nycomed; and a speaker for Bristol-Myers Squibb, Medice Arzneimittel, Novartis, and Roche. AR has received speaker’s honoraria from Medice, Takeda, Servier, Janssen, and neuraxpharm as well as grant support from Medice. SKS has received author’s and speaker’s honoraria as well as travel costs from Medice Arzneimittel and Takeda. CU, HW and JK have no conflict of interest to declare. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Rights and permissions
About this article
Cite this article
Strauß, M., Reif, A., Ulke, C. et al. Is brain arousal regulation a predictor of response to psychostimulant therapy in adult ADHD patients?. Eur Arch Psychiatry Clin Neurosci 270, 1073–1076 (2020). https://doi.org/10.1007/s00406-019-01085-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-019-01085-y